Page 2 - Regulatory Policy

ECB's next move is 'a cut' but policymakers spar on timing: Report

The ECB kept its key rate unchanged at a record high 4% last Thursday but sounded confident that inflation was coming under control

Sebi bans individual from securities mkt for flouting regulatory norms

Capital markets regulator Sebi has barred an individual from the securities markets for a period of five years as well as slapped a fine of Rs 30 lakh for flouting regulatory norms. Besides, the regulator restrained Mohit Manghnani (proprietor of Wealthit Global) from associating himself as a director or key managerial personnel with any listed public company or any Sebi-registered intermediary for a period of five years. Sebi also directed Manghnani to resolve all complaints received through the regulator's SCORES portal within a period of three months. The order came after the markets watchdog had passed an ex parte order against Manghnani and the latter approached the Securities Appellate Tribunal (SAT), which remanded the matter back to Sebi and directed the regulator to pass a fresh order. In its order passed on Friday, the regulator found that the noticee (Manghnani) did not cooperate with Sebi during the inspection and deceived its clients by not disclosing the information a

Intel calls off $5.4 bn semiconductor deal after failing to get approvals

Intel will terminate a USD 5.4 billion deal to acquire Israeli chip manufacturer Tower Semiconductor after China failed to sign off on the deal amid rising tensions with the United States. It was a mutual decision between Intel and Tower, the companies said Wednesday. Intel said that the deal was terminated due to the inability to obtain in a timely manner the regulatory approvals required under the merger agreement. Intel Corp. will pay Tower a termination fee of USD 353 million, the US semiconductor giant said. The deal required regulatory approval from several regulators worldwide including China, but Chinese regulators did not greenlight the deal by the August 15 transaction deadline, even after Intel CEO Patrick Gelsinger travelled to China last month in a bid to win them over. The scuttled deal between the two companies comes amid increasing US-China tensions, particularly as the US has tightened export controls and imposed restrictions aimed at crippling China's ability to

Generic 2.0: A call for regulatory vigilance

Biosimilars have the potential to offer affordable treatment to many currently untreatable diseases but striking a balance between affordability and regulation will be crucial

Regulation largest barrier in pharma, cos should focus on quality: Official

Union Pharma Secretary S Aparna on Thursday said regulations are the biggest barrier to market access in the sector globally, and exhorted local companies to focus on quality. Delivering a video message at the Eighth Global Pharmaceutical Quality Summit, Aparna backed the focus on regulations given the need to have products which are safe and effective. Pharma is highly regulated globally, and regulations contribute the single largest barrier to market access, she said. Indian manufacturing sector has wide-ranging players and the quality culture has to be built across the range, she said. Aparna said Indian industry, which has a very large number of small and medium businesses, is essentially a generic market, and stressed the need to innovate as per changing disease profile and other factors. Indian pharmaceuticals have scale, cost and quality advantages which have enabled companies to make a mark and garner market share in all countries across the world. Cost competitiveness can

Govt likely to introduce bills to amend competition, insolvency laws

The government is likely to propose amendments to the competition and insolvency laws as it seeks to further strengthen the regulatory regime as well as address the needs of new age markets.

Facing regulatory roadblocks, SoftBank drops sale of Arm to Nvidia

Arm named a new CEO on Tuesday who it said would help the British firm seek a public listing before March 2023

Political economy of regulatory reform

Dynamic markets call for periodic reform of regulatory agencies-notwithstanding their reluctance to keep pace with developments

Coronavirus impact: Sebi extends regulatory filing deadline for AIF, VC

The regulator said a need has been felt to further extend the timelines for regulatory filings for such entities

Govt mulls faster drug approval process, regulatory system overhaul

The industry, which has been lobbying for faster approvals for quite some time now, says the current pandemic should help expedite the reforms process

Is regulatory friction really unintended?

The real agenda of the government became clear in 2014 itself, even as businessmen, financial sector experts, and most of media continued to live under a mass delusion

Regulatory checks help fund houses tide over credit and liquidity crises

Holders of IL&FS papers would have faced more pain if the sectoral cap norms were not revised

Somasekhar Sundaresan: Rule by men - not the rule - of law

Governments have repeatedly ceded ground to judges - first, by not working on social issues that scream for attention, and second, by not legislating despite judicial attention being drawn to the issues